203 related articles for article (PubMed ID: 16816551)
1. Ex vivo culture of human colorectal tissue for the evaluation of candidate microbicides.
Fletcher PS; Elliott J; Grivel JC; Margolis L; Anton P; McGowan I; Shattock RJ
AIDS; 2006 Jun; 20(9):1237-45. PubMed ID: 16816551
[TBL] [Abstract][Full Text] [Related]
2. Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel.
Cranage M; Sharpe S; Herrera C; Cope A; Dennis M; Berry N; Ham C; Heeney J; Rezk N; Kashuba A; Anton P; McGowan I; Shattock R
PLoS Med; 2008 Aug; 5(8):e157; discussion e157. PubMed ID: 18684007
[TBL] [Abstract][Full Text] [Related]
3. Reverse transcriptase inhibitors as potential colorectal microbicides.
Herrera C; Cranage M; McGowan I; Anton P; Shattock RJ
Antimicrob Agents Chemother; 2009 May; 53(5):1797-807. PubMed ID: 19258271
[TBL] [Abstract][Full Text] [Related]
4. Colorectal microbicide design: triple combinations of reverse transcriptase inhibitors are optimal against HIV-1 in tissue explants.
Herrera C; Cranage M; McGowan I; Anton P; Shattock RJ
AIDS; 2011 Oct; 25(16):1971-9. PubMed ID: 21811139
[TBL] [Abstract][Full Text] [Related]
5. In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide.
Rohan LC; Moncla BJ; Kunjara Na Ayudhya RP; Cost M; Huang Y; Gai F; Billitto N; Lynam JD; Pryke K; Graebing P; Hopkins N; Rooney JF; Friend D; Dezzutti CS
PLoS One; 2010 Feb; 5(2):e9310. PubMed ID: 20174579
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 infection of human penile explant tissue and protection by candidate microbicides.
Fischetti L; Barry SM; Hope TJ; Shattock RJ
AIDS; 2009 Jan; 23(3):319-28. PubMed ID: 19114867
[TBL] [Abstract][Full Text] [Related]
7. Clinical development of microbicides for the prevention of HIV infection.
D'Cruz OJ; Uckun FM
Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390
[TBL] [Abstract][Full Text] [Related]
8. A human colorectal explant culture to evaluate topical microbicides for the prevention of HIV infection.
Abner SR; Guenthner PC; Guarner J; Hancock KA; Cummins JE; Fink A; Gilmore GT; Staley C; Ward A; Ali O; Binderow S; Cohen S; Grohskopf LA; Paxton L; Hart CE; Dezzutti CS
J Infect Dis; 2005 Nov; 192(9):1545-56. PubMed ID: 16206069
[TBL] [Abstract][Full Text] [Related]
9. Dose-response relationship between tissue concentrations of UC781 and explant infectibility with HIV type 1 in the RMP-01 rectal safety study.
Richardson-Harman N; Mauck C; McGowan I; Anton P
AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1422-33. PubMed ID: 22900504
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1.
Grivel JC; Elliott J; Lisco A; Biancotto A; Condack C; Shattock RJ; McGowan I; Margolis L; Anton P
AIDS; 2007 Jun; 21(10):1263-72. PubMed ID: 17545702
[TBL] [Abstract][Full Text] [Related]
11. Rectal microbicide development.
McGowan I; Dezzutti C
Curr Top Microbiol Immunol; 2014; 383():117-36. PubMed ID: 23612991
[TBL] [Abstract][Full Text] [Related]
12. Preclinical evaluation of the HIV-1 fusion inhibitor L'644 as a potential candidate microbicide.
Harman S; Herrera C; Armanasco N; Nuttall J; Shattock RJ
Antimicrob Agents Chemother; 2012 May; 56(5):2347-56. PubMed ID: 22330930
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo comparison of microbicide efficacies for preventing HIV-1 genomic integration in intraepithelial vaginal cells.
McElrath MJ; Ballweber L; Terker A; Kreger A; Sakchalathorn P; Robinson B; Fialkow M; Lentz G; Hladik F
Antimicrob Agents Chemother; 2010 Feb; 54(2):763-72. PubMed ID: 19949052
[TBL] [Abstract][Full Text] [Related]
14. Candidate polyanion microbicides inhibit HIV-1 infection and dissemination pathways in human cervical explants.
Fletcher PS; Wallace GS; Mesquita PM; Shattock RJ
Retrovirology; 2006 Aug; 3():46. PubMed ID: 16882346
[TBL] [Abstract][Full Text] [Related]
15. [Establishment of human colorectal tissue model in HIV-1 mucosal infection].
Yang Y; Liu AP; Meng QL; Xu JQ; Zhang XY
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Feb; 45(2):127-31. PubMed ID: 21426791
[TBL] [Abstract][Full Text] [Related]
16. Development of HIV-1 rectal-specific microbicides and colonic tissue evaluation.
Dezzutti CS; Russo J; Wang L; Abebe KZ; Li J; Friend DR; McGowan IM; Rohan LC
PLoS One; 2014; 9(7):e102585. PubMed ID: 25025306
[TBL] [Abstract][Full Text] [Related]
17. Molecular umbrellas: a novel class of candidate topical microbicides to prevent human immunodeficiency virus and herpes simplex virus infections.
Madan RP; Mesquita PM; Cheshenko N; Jing B; Shende V; Guzman E; Heald T; Keller MJ; Regen SL; Shattock RJ; Herold BC
J Virol; 2007 Jul; 81(14):7636-46. PubMed ID: 17494078
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic Activity of Dapivirine and Maraviroc Single Entity and Combination Topical Gels for HIV-1 Prevention.
Dezzutti CS; Yandura S; Wang L; Moncla B; Teeple EA; Devlin B; Nuttall J; Brown ER; Rohan LC
Pharm Res; 2015 Nov; 32(11):3768-81. PubMed ID: 26078001
[TBL] [Abstract][Full Text] [Related]
19. Ranpirnase Reduces HIV-1 Infection and Associated Inflammatory Changes in a Human Colorectal Explant Model.
Brand RM; Siegel A; Myerski A; Metter EJ; Engstrom J; Brand RE; Squiquera L; Hodge T; Sulley J; Cranston RD; McGowan I
AIDS Res Hum Retroviruses; 2018 Oct; 34(10):838-848. PubMed ID: 29936861
[TBL] [Abstract][Full Text] [Related]
20. Current Concepts for the IND-Directed Development of Microbicide Products to Prevent the Sexual Transmission of HIV.
Buckheit KW; Furlan-Freguia C; Ham AS; Buckheit RW
Curr Top Med Chem; 2016; 16(10):1118-34. PubMed ID: 26324047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
